These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 6603592)

  • 1. Myasthenia gravis. Immunological studies in a young child treated with thymectomy and immunosuppressive drugs.
    Bjerre I; Hallberg A
    Neuropediatrics; 1983 May; 14(2):106-9. PubMed ID: 6603592
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [A case of myasthenia gravis, who developed minimal change nephrotic syndrome during immunosuppressive therapy after thymectomy].
    Takahashi K; Inoue Y; Matsuda O; Takemura T; Yoshimura A
    Nihon Jinzo Gakkai Shi; 2000 Jul; 42(5):394-8. PubMed ID: 10998921
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical correlates with anti-MuSK antibodies in generalized seronegative myasthenia gravis.
    Evoli A; Tonali PA; Padua L; Monaco ML; Scuderi F; Batocchi AP; Marino M; Bartoccioni E
    Brain; 2003 Oct; 126(Pt 10):2304-11. PubMed ID: 12821509
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Scientific overview of myasthenia gravis and an assessment of the role of plasmapheresis.
    Tindall RS
    Prog Clin Biol Res; 1982; 106():113-42. PubMed ID: 6757936
    [No Abstract]   [Full Text] [Related]  

  • 5. [Myasthenia gravis; clinical aspects, pathophysiology and treatment].
    Oosterhuis HJ
    Ned Tijdschr Geneeskd; 1983 Sep; 127(39):1765-71. PubMed ID: 6314161
    [No Abstract]   [Full Text] [Related]  

  • 6. Anti-musk antibody after thymectomy in a previously seropositive myasthenic child.
    Saulat B; Maertens P; Hamilton WJ; Bassam BA
    Neurology; 2007 Aug; 69(8):803-4. PubMed ID: 17709714
    [No Abstract]   [Full Text] [Related]  

  • 7. Plasmapheresis and immunosuppressive drug therapy in myasthenia gravis.
    Dau PC; Lindstrom JM; Cassel CK; Denys EH; Shev EE; Spitler LE
    N Engl J Med; 1977 Nov; 297(21):1134-40. PubMed ID: 917042
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of thymectomy on peripheral lymphocyte subsets in myasthenia gravis: selective effect on T-cells in patients with thymic atrophy.
    Haynes BF; Harden EA; Olanow CW; Eisenbarth GS; Wechsler AS; Hensley LL; Roses AD
    J Immunol; 1983 Aug; 131(2):773-7. PubMed ID: 6408188
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Therapeutic strategy in myasthenia gravis].
    Tranchant C
    Rev Neurol (Paris); 2009 Feb; 165(2):149-54. PubMed ID: 19233080
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Myasthenia gravis (second of two parts).
    Drachman DB
    N Engl J Med; 1978 Jan; 298(4):186-93. PubMed ID: 339085
    [No Abstract]   [Full Text] [Related]  

  • 11. In vitro T-cell dependent B-cell activity in myasthenia gravis.
    Limburg PC; Hummel-Tappel E; Oosterhuis HJ; The TH
    Clin Exp Immunol; 1985 Jul; 61(1):31-8. PubMed ID: 3876181
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Plasma exchange in myasthenia gravis].
    Redeker M; Meyer-Wahl L
    Nervenarzt; 1982 Dec; 53(12):729-32. PubMed ID: 7155236
    [No Abstract]   [Full Text] [Related]  

  • 13. Low-dose tacrolimus for two cases of myasthenia gravis with invasive thymoma that relapsed shortly after thymectomy.
    Tsukaguchi M; Shimamura M; Ikeda K; Urai Y; Sasaki I; Deguchi K; Touge T; Takeuchi H; Kuriyama S
    J Neurol Sci; 2005 Apr; 231(1-2):85-8. PubMed ID: 15792826
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Juvenile myasthenia gravis].
    Ohno K; Sahashi K
    Ryoikibetsu Shokogun Shirizu; 2001; (36):340-3. PubMed ID: 11596404
    [No Abstract]   [Full Text] [Related]  

  • 15. Autologous mixed lymphocyte reaction in patients with myasthenia gravis: correlation with disease activity.
    Greenberg SJ; Olanow CW; Dawson DV; Crane B; Roses AD
    J Immunol; 1984 Mar; 132(3):1229-36. PubMed ID: 6229579
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Clinical and biological evolution of myasthenia gravis after thymectomy in a 13-year-old girl].
    Denizot M; Fulpius BW; Cox JN; Ferrier PE
    Helv Paediatr Acta; 1979 Sep; 34(4):375-80. PubMed ID: 521303
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Therapeutic options in autoimmune myasthenia gravis.
    García-Carrasco M; Escárcega RO; Fuentes-Alexandro S; Riebeling C; Cervera R
    Autoimmun Rev; 2007 Jun; 6(6):373-8. PubMed ID: 17537383
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment and outcome of myasthenia gravis: retrospective multi-center analysis of 470 Japanese patients, 1999-2000.
    Kawaguchi N; Kuwabara S; Nemoto Y; Fukutake T; Satomura Y; Arimura K; Osame M; Hattori T;
    J Neurol Sci; 2004 Sep; 224(1-2):43-7. PubMed ID: 15450770
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Plasma exchange combined with immunosuppressive therapy in myasthenia gravis].
    Tanaka M; Nagai H; Mori S; Miyatake T; Shinada S
    No To Shinkei; 1982 Jul; 34(7):699-703. PubMed ID: 7138697
    [No Abstract]   [Full Text] [Related]  

  • 20. [Myasthenia gravis. Indications, aims and methods of intensive therapy].
    Braschi A; Scherini A; Carbonera D; Mapelli A; Bellinzona G; Bobbio Pallavicini F; Dionigi R; Gasperi A
    Minerva Anestesiol; 1979 Nov; 45(11):871-81. PubMed ID: 548812
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.